Resveratrol mainly stimulates the glycolytic ATP synthesis flux and not the mitochondrial one: A saturation transfer NMR study in perfused and isolated rat liver

Pharmacological Research

Volumn 78, Issue , 2013, Pages 11-17

  Beauvieux, Marie Christine ^a   Stephant, Alan ^a   Gin, Henri ^b   Serhan, Nizar ^a   Couzigou, Patrice ^b   Gallis, Jean Louis ^a  

^a CNRS University Bordeaux Segalen   (France)

^b HAUT LÉVÊQUE HOSPITAL   (France)

Author keywords

ATP; Glycolysis; Resveratrol; Saturation transfer NMR

Indexed keywords

ADENOSINE TRIPHOSPHATE; RESVERATROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; ENZYME SYNTHESIS; GLYCOLYSIS; ISOLATED LIVER; LIVER PERFUSION; MALE; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN TRANSPORT; RAT;

AMPK; AMPKINASE; APPARENT CATALYTIC TIME CONSTANT; APPARENT SYNTHESIS TIME CONSTANT; ATP; CHEMICAL ISCHEMIA; CI; G3PDH; GLYCERALDEHYDE-3-PHOSPHATE-DEHYDROGENASE; GLYCOLYSIS; IAA; INORGANIC PHOSPHATE; IODACETATE; IODOACETATE (PUBCHEM CID: 5240); K(D MITO); K(S); KHB; KREBS-HENSELEIT BUFFER; NMR; NUCLEAR MAGNETIC RESONANCE; PFK; PHOSPHOFRUCTOKINASE; PI; POTASSIUM CYANIDE KCN (PUBCHEM CID: 9032); R; RATE OF ATP SYNTHESIS BY ST; RATE OF MITOCHONDRIAL ATP SYNTHESIS; RESVERATROL; RSV; SATURATION TRANSFER; SATURATION TRANSFER NMR; SIRT1; SIRTUIN 1; ST; TCA; TRANS-RESVERATROL; TRANS-RESVERATROL (PUBCHEM CID: 445154); TRICARBOXYLIC CYCLE; VS; WET WEIGHT; WW;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANTIOXIDANTS; GLYCOLYSIS; LIVER; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MITOCHONDRIA; PHOSPHORYLATION; RATS; RATS, WISTAR; STILBENES;

EID: 84886573158     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2013.09.007     Document Type: Article

References (50)

1. S. Timmers, E. Konings, L. Bilet, R.H. Houtkooper, T. van de Weijer, and G.H. Goossens Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans Cell Metab 14 2011 612 622
2. L. Fontana, L. Partridge, and V.D. Longo Extending healthy life span - from yeast to humans Science 328 2010 321 326
3. P.L. da Luz, L. Tanaka, P.C. Brum, P.M. Dourado, D. Favarato, and J.E. Krieger Red wine and equivalent oral pharmacological doses of resveratrol delay vascular aging but do not extend life span in rats Atherosclerosis 224 2012 136 142
4. J.A. Baur Resveratrol, sirtuins, and the promise of a DR mimetic Mech Ageing Dev 131 2010 261 269
5. J.M. Smoliga, J.A. Baur, and H.A. Hausenblas Resveratrol and health - a comprehensive review of human clinical trials Mol Nutr Food Res 55 2011 1129 1141
6. J. Tomé-Carneiro, M. Larrosa, A. González-Sarrías, F.A. Tomás-Barberán, M.T. García-Conesa, and J.C. Espín Resveratrol and clinical trials the crossroad from in vitro studies to human evidence Curr Pharm Des 19 34 2013 6064 6093
7. C.H. Cottart, V. Nivet-Antoine, and J.L. Beaudeux Review of recent data on the metabolism, biological effects, and toxicity of resveratrol in humans Mol Nutr Food Res 2013 10.1002/mnfr.201200589
8. J. Tomé-Carneiro, M. Larrosa, M.J. Yáñez- Gascón, A. Dávalos, J. Gil-Zamorano, and M. Gonzálvez One-year supplementation with a grape extract containing resveratrol modulates inflammatory-related microRNAs and cytokines expression in peripheral blood mononuclear cells of type 2 diabetes and hypertensive patients with coronary artery disease Pharmacol Res 72 2013 69 82
9. S. Shigematsu, S. Ishida, M. Hara, N. Takahashi, H. Yoshimatsu, and T. Sakata Resveratrol, a red wine constituent polyphenol, prevents superoxide-dependent inflammatory responses induced by ischemia/reperfusion, platelet-activating factor, or oxidants Free Radic Biol Med 34 2003 810 817 (Pubitemid 36316064)
10. M. Frombaum, S. Le Clanche, D. Bonnefont-Rousselot, and D. Borderie Antioxidant effects of resveratrol and other stilbene derivatives on oxidative stress and*NO bioavailability: potential benefits to cardiovascular diseases Biochimie 94 2012 269 276
11. I. Muqbil, F.W. Beck, B. Bao, F.H. Sarkar, R.M. Mohammad, and S.M. Hadi Old wine in a new bottle: the Warburg effect and anticancer mechanisms of resveratrol Curr Pharm Des 18 2012 1645 1654
12. L.K. Park, S. Friso, and S.W. Choi Nutritional influences on epigenetics and age-related disease Proc Nutr Soc 71 2012 75 83
13. M. Lagouge, C. Argmann, Z. Gerhart-Hines, H. Meziane, C. Lerin, and F. Daussin Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha Cell 127 2006 1109 1122 (Pubitemid 44894520)
14. A. Camins, F.X. Sureda, F. Junyent, E. Verdaguer, J. Folch, and C. Pelegri Sirtuin activators: designing molecules to extend life span. Review Biochim Biophys Acta 1799 2010 740 749
15. J.N. Feige, M. Lagouge, C. Canto, A. Strehle, S.M. Houten, and J.C. Milne Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation Cell Metab 8 2008 347 358
16. M. Pacholec, J.E. Bleasdale, B. Chrunyk, D. Cunningham, D. Flynn, and R.S. Garofalo SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1 J Biol Chem 285 2010 8340 8351
17. Y. Hu, J. Liu, J. Wang, and Q. Liu The controversial links among calorie restriction, SIRT1, and resveratrol Free Radic Biol Med 51 2011 250 256
18. N.L. Price, A.P. Gomes, A.J. Ling, F.V. Duarte, A. Martin-Montalvo, and B.J. North SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function Cell Metab 15 2012 675 690
19. J.H. Um, S.J. Park, H. Kang, S.T. Yang, M. Foretz, and M.W. McBurney AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol Diabetes 59 2010 554 563
20. M. Foretz, and B. Viollet Regulation of hepatic metabolism by AMPK J Hepatol 54 2011 827 829
21. H.C. Lee, and Y.H. Wei Mitochondria and aging Adv Exp Med Biol 942 2012 311 327
22. A.K. Groen Quantification of control in studies on intermediary metabolism A.K. Groen, Control of mitochondrial oxidative phosphorylation in the intact cell 1984 BV Kanters Alblasserdam, Netherlands 61 66
23. J.L. Gallis, P. Tissier, H. Gin, and M.C. Beauvieux Decrease in oxidative phosphorylation yield in presence of butyrate in perfused liver isolated from fed rats BMC Physiol 28 7 2007 8
24. 31P NMR study of ATP and sn-glycerol-3-phosphate on isolated and perfused rat liver Pharmacol Res 65 2012 387 395
25. S. Forsen, and R.A. Hoffman Study of moderately chemical exchange reactions by means of Nuclear Magnetic double Resonance J Chem Phys 39 1963 2892 2901
26. D.E. Befroy, K. Falk Petersen, D.L. Rothman, and G.I. Shulman Assessment of in vivo mitochondrial metabolism by magnetic resonance spectroscopy Methods Enzymol 457 2009 373 393
27. A.P. Koretsky, S. Wang, M.P. Klein, T.L. James, and M.W. Weiner 31P NMR saturation transfer measurements of phosphorus exchange reactions in rat heart and kidney in situ Biochemistry 25 1986 77 84 (Pubitemid 16053082)
28. W.J. Thoma, and K. Uǧurbil Saturation-transfer studies of ATP-Pi exchange in isolated perfused rat liver Biochim Biophys Acta 893 1987 225 231
29. P.S. Hsieh, and R.S. Balaban Saturation and inversion transfer studies of creatine kinase kinetics in rabbit skeletal muscle in vivo Magn Reson Med 7 1988 56 64
30. F. Joubert, P. Mateo, B. Gillet, J.C. Beloeil, J.L. Mazet, and J.A. Hoerter CK flux or direct ATP transfer: versatility of energy transfer pathways evidenced by NMR in the perfused heart Mol Cell Biochem 256-257 2004 43 58 (Pubitemid 38181234)
31. 31P magnetization transfer study Magn Reson Med 38 1997 551 557 (Pubitemid 27419218)
32. J. Zheng, and V.D. Ramirez Inhibition of mitochondrial proton F0F1-ATPase/ATP synthase by polyphenolic phytochemicals Br J Pharmacol 130 2000 1115 1123 (Pubitemid 30453547)
33. M.C. Beauvieux, P. Tissier, H. Gin, P. Canioni, and J.L. Gallis Butyrate impairs energy metabolism in isolated perfused liver of fed rats J Nutr 131 2001 1986 1992 (Pubitemid 32661068)
34. M.C. Beauvieux, H. Roumes, N. Robert, H. Gin, V. Rigalleau, and J.L. Gallis Butyrate ingestion improves hepatic glycogen storage in the re-fed rat BMC Physiol 8 2008 19
35. T. Poole, and P. English The UFAW handbook on the care and management of laboratory animals. Volume 1: terrestrial vertebrates 7th ed. 1999 Blackwell Sciences Ltd. Oxford, UK
36. J.A. Crowell, P.J. Korytko, R.L. Morrissey, T.D. Booth, and B.S. Levine Resveratrol-associated renal toxicity Toxicol Sci 82 2004 614 619 (Pubitemid 39600090)
37. E.H. Siemann, and L.L. Creasy Concentration of the phytoalexin resveratrol in wine Am J Enol Viticult 43 1992 49 52
38. M.C. Beauvieux, P. Tissier, P. Couzigou, H. Gin, P. Canioni, and J.L. Gallis Ethanol perfusion increases the yield of oxidative phosphorylation in isolated liver of fed rats Biochim Biophys Acta 1570 2002 135 140 (Pubitemid 34457810)
39. 31P cryo-NMR J Biol Chem 265 1990 22097 22100 (Pubitemid 120014272)
40. S. Dufour, E. Thiaudière, J.L. Gallis, P. Canioni, and P. Diolez Yield of oxidative phosphorylation in resting perfused liver: saturation and biochemical analyses Magn Reson Mater Phys Biol Med 4 1996 329
41. M.D. Brand, M.E. Harper, and H.C. Taylor Control of the effective P/O ratio of oxidative phosphorylation in liver mitochondria and hepatocytes Biochem J 291 1993 739 748 (Pubitemid 23148447)
42. P.E. Linnett, and R.B. Beechey Inhibitors of the ATP synthetase system Methods Enzymol 55 1979 472 518
43. J.L. Kipp, and V.D. Ramirez Effect of estradiol, diethylstilbestrol, and resveratrol on F0F1-ATPase activity from mitochondrial preparations of rat heart, liver, and brain Endocrine 15 2001 165 175 (Pubitemid 32977326)
44. A.C. Moreira, A.M. Silva, M.S. Santos, and V.A. Sardão Resveratrol affects differently rat liver and brain mitochondrial bioenergetics and oxidative stress in vitro: investigation of the role of gender Food Chem Toxicol 53C 2012 18 26
45. 2+ Yao Xue Xue Bao (Acta Pharm Sin) 382 2003 81 84
46. X. Hou, S. Xu, K.A. Maitland-Toolan, K. Sato, B. Jiang, and Y. Ido SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase J Biol Chem 283 2008 20015 20026
47. J.H. Um, S.J. Park, H. Kang, S. Yang, M. Foretz, and M.W. McBurney AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol Diabetes 9 2010 554 563
48. G. Alberdi, V.M. Rodríguez, M.T. Macarulla, J. Miranda, I. Churruca, and M.P. Portillo Hepatic lipid metabolic pathways modified by resveratrol in rats fed an obesogenic diet Nutrition 29 2013 562 567
49. S.J. Park, F. Ahmad, A. Philp, K. Baar, T. Williams, and H. Luo Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases Cell 148 2012 421 433
50. B. Viollet, L. Lantier, J. Devin-Leclerc, S. Hebrard, C. Amouyal, and R. Mounier Targeting the AMPK pathway for the treatment of Type 2 diabetes Front Biosci 14 2009 3380 3400